If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
385.00    5.00 (1.32%)
Bid:
370.00
Ask:
400.00
Spread: 30.00 (8.108%)
Market Cap: £36.79m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

Trading Update

18 Sep 2018 14:00

RNS Number : 1506B
Cropper(James) PLC
18 September 2018
 

18 September 2018

For release at 1400

 

 

James Cropper plc

(the "Company")

Trading Update

 

James Cropper, the advanced materials and paper products group, provides the following trading update.

Since full year results to 31 March 2018 the strength of the pulp price has continued and it remains above levels forecast by the Group's external specialist and we now expect these higher price levels to continue for the foreseeable future. In this difficult environment, the focus of the James Cropper Paper Division ("Paper") is on improving sales mix whilst seeking to recover margin through calibrated price increases. Nevertheless, the sustained current high pulp price will have a material impact on the division's and the Group's results for the current financial year.

Technical Fibre Products Division ("TFP") is continuing to demonstrate strong and steady sales and profit growth in the key markets such as aerospace, defence and fuel cells, with results in line with management's expectations. TFP's current projections indicate the Division will be close to existing capacity limits in the coming years. Accordingly, the decision has been made to expand capacity by a further 50 per cent to be available from around the start of 2021. James Cropper 3DP, trading as "Colourform", is fulfilling a number of commercial contracts and enjoys a growing pipeline. The division is delivering on sales growth, generating revenue, and will provide profits for the Group as it scales.

The net impact of the higher pulp price on the Group's pre-tax profits for the current year is now expected to be a further £2.0 million and as a matter of prudence the Board is factoring the effect of the current higher price into its expectations for future periods.

The Board takes into account the strong prospects for TFP and Colourform against the difficult pulp price environment for the paper business and remains very confident in the strategy and subsequent growth for all divisions across the Group. The Company expects to announce its half year results to 29 September 2018 in the week commencing 12 November 2018.

Mark Cropper, Chairman, commented:

"The persistently higher pulp prices is impacting the returns from our paper business. Against this the success of TFP and 3DP reflects the continuing efforts of the Board to grow advanced technology businesses with reduced exposure to the uncertainties of commodity prices."

 

Enquiries:

James Cropper PLC (Aim:CRPR)

Isabelle Maddock, Group Finance Director

Jim Aldridge, Company Secretary

Tel: +44 (0) 1539 722002

www.cropper.com

Stockdale Securities Limited

Robert Finlay, Henry Willcocks

Richard Johnson

Tel: + 44 (0) 207 601 6100

www.stockdalesecurities.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFUFEAFASEIU
Date   Source Headline
10th Nov 20215:57 pmRNSRecord Date
9th Nov 20217:00 amRNSDirectorate Change
9th Nov 20217:00 amRNSHalf-year Report
4th Nov 20217:00 amRNSDirectorate Change
24th Sep 20211:44 pmRNSDirector/PDMR Shareholding
9th Sep 20215:35 pmRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSGrant of Awards under Long Term Incentive Plan
5th Aug 20217:00 amRNSDirector/PDMR Shareholding
4th Aug 20217:00 amRNSDirector/PDMR Shareholding
28th Jul 202111:00 amRNSAGM Statement and Trading Update
27th Jul 202110:27 amRNSDirector/PDMR Shareholding
23rd Jul 20219:52 amRNSDirector/PDMR Shareholding
23rd Jul 20217:00 amRNSUpdate for visitors to the AGM
21st Jul 20217:00 amRNSDirector/PDMR Shareholding
6th Jul 20217:46 amRNSDirector/PDMR Shareholding
1st Jul 20212:30 pmRNSHolding(s) in Company
22nd Jun 20218:36 amRNSDirectorate Change
22nd Jun 20217:00 amRNSFinal Results
29th Mar 20217:00 amRNSDirector Dealing
25th Mar 20217:00 amRNSDirector/PDMR Shareholding
15th Mar 20219:31 amRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNSTrading Update
18th Jan 20217:00 amRNSAcquisition
18th Dec 202011:05 amRNSDirector/PDMR Shareholding
24th Nov 20207:00 amRNSDirector/PDMR Shareholding
17th Nov 20202:06 pmRNSSecond Price Monitoring Extn
17th Nov 20202:00 pmRNSPrice Monitoring Extension
10th Nov 20207:00 amRNSHalf-year Report
5th Aug 20207:00 amRNSGrant of Awards under Long Term Incentive Plan
31st Jul 20207:00 amRNSDirector/PDMR Shareholding
30th Jul 20209:41 amRNSResult of AGM
29th Jul 20207:00 amRNSAGM Statement and Trading Update
27th Jul 20201:47 pmRNSDirector/PDMR Shareholding
27th Jul 20209:00 amRNSDirectorate Change
23rd Jun 20207:00 amRNSFinal Results
1st May 20207:00 amRNSYear end and COVID 19 trading update
24th Mar 20203:57 pmRNSCOVID 19 update
20th Feb 20209:45 amRNSDirector Dealing
14th Feb 202010:13 amRNSDirector Dealing
30th Jan 20208:55 amRNSDirector/PDMR Shareholding
24th Jan 20204:30 pmRNSDirector/PDMR Shareholding
21st Jan 20202:00 pmRNSHolding(s) in Company
13th Jan 202011:05 amRNSDirector/PDMR Shareholding
17th Dec 201912:24 pmRNSDirector/PDMR Shareholding
13th Dec 20197:00 amRNSDirectors' Dealings
29th Nov 201910:42 amRNSDirector/PDMR Shareholding
19th Nov 20197:00 amRNSHalf-year Report
24th Sep 20197:00 amRNSDirector/PDMR Shareholding
17th Sep 201911:20 amRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSDirectors' Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.